Hospital de Madrid Norte-Sanchinarro.

Madrid 28050

0 studies enrolling now · 5 studies all time

What they study most

Advanced, Androgen Receptor Positive Triple Negative Breast Cancer, Breast Cancer, Colorectal Neoplasms, Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma, Peripheral T-cell Lymphoma

Studies at this site

• Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer — Completed
• Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer — Completed
• Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE) — Stopped early
• Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients — Stopped early
• A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL). — Stopped early